(Q39981390)

16 September 2017

title

A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine (English)

1 reference

16 September 2017

0 references

0 references

0 references

1 reference

Jens-Peter Gregersen

1

1 reference

16 September 2017

language of work or name

English

0 references

publication date

18 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

26

1 reference

16 September 2017

page(s)

3332-3340

1 reference

describes a project that uses

16 September 2017

MDCK 33016

0 references

cites work

The annual production cycle for influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Vaccine manufacturing: challenges and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Avian and pandemic influenza: an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Infection of a polarized epithelial cell line with wild-type reovirus leads to virus persistence and altered cellular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Role of tight junctions of polarized epithelial MDCK cells in the replication of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Evaluation of different continuous cell lines in the isolation of mumps virus by the shell vial method from clinical samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Diagnosis of respiratory tract viruses in 24 h by immunofluorescent staining of shell vial cultures containing Madin-Darby Canine Kidney (MDCK) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

Evidence of pestivirus RNA in human virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

7 January 2021

inferred from DOI database lookup

Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

7 January 2021

inferred from DOI database lookup

A comparison of avian and mammalian cell cultures for the propagation of avian reovirus WVU 2937.

1 reference

12 December 2020

Comparison of the characteristics of avian reoviruses isolated from the digestive and respiratory tract, with viruses isolated from the synovia

1 reference

12 December 2020

Addressing immunization barriers, benefits, and risks

1 reference

12 December 2020

Experience with viral contamination in cell culture.

1 reference

12 December 2020

Polarized budding of measles virus is not determined by viral surface glycoproteins.

2 references

12 December 2020

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.075

7 January 2021

inferred from DOI database lookup

Optimized detection of respiratory viruses in nasopharyngeal secretions.

1 reference

12 December 2020

In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus

1 reference

12 December 2020

Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine)

1 reference

12 December 2020

Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine

1 reference

12 December 2020

International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice

1 reference

12 December 2020

Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.

1 reference

12 December 2020

Adventitious agents and vaccines

1 reference

12 December 2020

10.1016/J.VACCINE.2008.03.075

Identifiers

DOI

1 reference

16 September 2017

1 reference